Edit |   |
---|---|
Antigenic Specificity | KIRD2 |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | Neut, ELISA, IF, IP, FuncS, FC, |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Afuco™ Anti-KIRD2 ADCC Recombinant Antibody (Lirilumab), ADCC Enhanced. This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human KIRD2 subgroup. Lirilumab is a human monoclonal antibody designed for the treatment of cancer. |
Immunogen | The details of the immunogen for this antibody are not available. |
Other Names | Lirilumab; 1000676-41-4; IPH 2101; IPH2101; 1-7F9; IPH 2102; IPH2102; BMS-986015; Killer-cell immunoglobulin-like receptors; KIRs; KIR2DL1/2/3 |
Gene, Accession # | n/a |
Catalog # | AFC-TAB-757 |
Price | please inquire |
Order / More Info | KIRD2 Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |